- RON2.22bn
- RON1.63bn
- RON945.65m
- 75
- 60
- 81
- 86
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.86 | ||
| Price to Tang. Book | 1.91 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.34 | ||
| EV to EBITDA | 7.58 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 15.01% | ||
| Return on Equity | 17.46% | ||
| Operating Margin | 19.33% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | RONm | 559.01 | 557.96 | 710.93 | 759.63 | 945.65 | n/a | n/a | 15.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -79.48 | +28.37 | +56.88 | -13.31 | +102.89 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zentiva SA is a Romania-based company engaged in the pharmaceutical industry. The Company is primarily engaged in the production and commercialization of pharmaceutical preparations. The Company’s portfolio includes approximately 280 products and drugs for cardiovascular, nervous and digestive systems; pain treatment, and urological and anti-inflammatory diseases, among others. Additionally, the Company is active in the production of dietary supplements and vitamins. It has production sites in Czech Republic, Slovakia, Romania and Turkey. As of December 31, 2011, Venoma Holdings Limited held a 50.98% stake in Zentiva SA. The Company had one wholly owned subsidiary, Pallady Business Park SRL, as of December 31, 2011.
Directors
- Nicholas Haggar CHM
- Simona Cocos CEO (52)
- Margareta Tanase COO (59)
- Georgeta Danu CAO
- Kenneth Lynard NED
- Francois Marchand NID
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 9th, 1991
- Public Since
- August 13th, 1998
- No. of Employees
- 952
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Bucharest Stock Exchange- Shares in Issue
- 697,017,040
- Address
- Bvd. Theodor Pallady, nr. 50., Sector 3, BUCURESTI, 032266
- Web
- https://www.zentiva.ro/
- Phone
- +40 213047200
- Auditors
- Ernst & Young LLP
Upcoming Events for SCD
Similar to SCD
Antibiotice SA
Bucharest Stock Exchange
Biofarm SA
Bucharest Stock Exchange
FAQ
As of Today at 19:25 UTC, shares in Zentiva SA are trading at RON3.18. This share price information is delayed by 15 minutes.
Shares in Zentiva SA last closed at RON3.18 and the price had moved by +61.42% over the past 365 days. In terms of relative price strength the Zentiva SA share price has outperformed the FTSE Global All Cap Index by +51.54% over the past year.
There is no consensus recommendation for this security.
Zentiva SA does not currently pay a dividend.
Zentiva SA does not currently pay a dividend.
Zentiva SA does not currently pay a dividend.
To buy shares in Zentiva SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of RON3.18, shares in Zentiva SA had a market capitalisation of RON2.22bn.
Here are the trading details for Zentiva SA:
- Country of listing: Romania
- Exchange: BUH
- Ticker Symbol: SCD
Based on an overall assessment of its quality, value and momentum Zentiva SA is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zentiva SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +17.21%.
As of the last closing price of RON3.18, shares in Zentiva SA were trading +21.42% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Zentiva SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at RON3.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Zentiva SA's management team is headed by:
- Nicholas Haggar - CHM
- Simona Cocos - CEO
- Margareta Tanase - COO
- Georgeta Danu - CAO
- Kenneth Lynard - NED
- Francois Marchand - NID